TP53 and cancer: GSEA analysis indicated that DHX33 is involved in various immune/cancer-related signaling pathways, including cytokine–cytokine receptor interaction, JAK/STAT signaling pathway, complement and coagulation cascades, chemokine signaling pathway, T cell receptor signaling pathway, and P53 signaling pathway (Fig. 6A–F).